Therapy for hyperthermia-induced seizures in Scn1a mutant rats

Epilepsia

Volumn 52, Issue 5, 2011, Pages 1010-1017

  Hayashi, Keiichiro ^a   Ueshima, Satoshi ^b   Ouchida, Mamoru ^a   Mashimo, Tomoji ^c   Nishiki, Teiichi ^a   Sendo, Toshiaki ^b   Serikawa, Tadao ^c   Matsui, Hideki ^a   Ohmori, Iori ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Animal models; Febrile seizure; Generalized epilepsy with febrile seizures plus; Scn1a gene; Severe myoclonic epilepsy of infancy

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; DIAZEPAM; GABAPENTIN; HOT WATER; PHENOBARBITAL; POTASSIUM BROMIDE; TOPIRAMATE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FEBRILE CONVULSION; HYPERTHERMIA; MALE; MOTOR COORDINATION; MYOCLONUS EPILEPSY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TREATMENT RESPONSE;

ANIMALS; ANTICONVULSANTS; BROMIDES; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; EPILEPSY, GENERALIZED; FEVER; HUMANS; MALE; MUTATION; NERVE TISSUE PROTEINS; POTASSIUM COMPOUNDS; RATS; RATS, MUTANT STRAINS; SEIZURES, FEBRILE; SODIUM CHANNELS; VIDEO RECORDING;

EID: 79955924747     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03046.x     Document Type: Article

References (39)

1. Baulac S, Gourfinkel-An I, Nabbout R, Huberfeld G, Serratosa J, Leguern E, Baulac M,. (2004) Fever, genes, and epilepsy. Lancet Neurol 3: 421-430. (Pubitemid 38796480)
2. Borowicz KK, Luszczki JJ, Duda AM, Czuczwar SJ,. (2003) Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy. Epilepsia 44: 640-646. (Pubitemid 36554631)
3. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ,. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19: 3248-3257. (Pubitemid 29174016)
4. Ceulemans B, Boel M, Claes L, Dom L, Willekens H, Thiry P, Lagae L,. (2004) Severe myoclonic epilepsy in infancy: toward an optimal treatment. J Child Neurol 19: 516-521. (Pubitemid 39481251)
5. Chadman KK, Yang M, Crawley JN,. (2009) Criteria for validating mouse models of psychiatric diseases. Am J Med Genet B Neuropsychiatr Genet 150B: 1-11.
6. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P,. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68: 1327-1332. (Pubitemid 32510608)
7. Coppola G, Capovilla G, Montagnini A, Romeo A, Spanà M, Tortorella G, Veggiotti P, Viri M, Pascotto A,. (2002) Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 49: 45-48. (Pubitemid 34304205)
8. Eadie MJ,. (2001) Therapeutic drug monitoring-antiepileptic drugs. Br J Clin Pharmacol 52 (suppl 1): 11S-20S. (Pubitemid 32823028)
9. Granero GE, Longhi MR, Becker C, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM., (2007) Biowaiver monographs for immediate release solid oral dosage forms: Acetazolamide. J Pharm Sci 97: 3691-3699.
10. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O,. (1998) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39: 508-512. (Pubitemid 28221807)
11. Haigh JR, Feely M,. (1988) Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci 9: 361-366.
12. Hattori J, Ouchida M, Ono J, Miyake S, Maniwa S, Mimaki N, Ohtsuka Y, Ohmori I,. (2008) A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 49: 626-633. (Pubitemid 351661052)
13. Hauser WA,. (1994) The prevalence and incidence of convulsive disorders in children. Epilepsia 35 (suppl 2): S1-S6. (Pubitemid 24033693)
14. Holtzman D, Obana K, Olson J,. (1981) Hyperthermia-induced seizures in the rat pup: a model for febrile convulsions in children. Science 213: 1034-1036.
15. Horn CS, Ater SB, Hurst DL,. (1986) Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 2: 340-345. (Pubitemid 17029893)
16. Ishihara K, Kushida H, Yuzurihara M, Wakui Y, Yanagisawa T, Kamei H, Ohmori S, Kitada M,. (2000) Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica. J Pharm Pharmacol 52: 1023-1029.
17. Klauenberg BJ, Sparber SB,. (1984) A kindling-like effect induced by repeated exposure to heated water in rats. Epilepsia 25: 292-301. (Pubitemid 14121638)
18. Macdonald RL,. (2002) Carbamazepine. In, Levy RH, Mattson RH, Meldrum BS, Perucca E, (Eds) Antiepileptic drugs. Lippincott Williams & Wilkins, Philadelphia, pp. 227-235.
19. Martin MS, Dutt K, Papale LA, Dubé CM, Dutton SB, de Haan G, Shankar A, Tufik S, Meisler MH, Baram TZ, Goldin AL, Escayg A,. (2010) Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 285: 9823-9834.
20. Mashimo T, Yanagihara K, Tokuda S, Voigt B, Takizawa A, Nakajima R, Kato M, Hirabayashi M, Kuramoto T, Serikawa T,. (2008) An ENU-induced mutant archive for gene targeting in rats. Nat Genet 40: 514-515. (Pubitemid 351601233)
21. Mashimo T, Ohmori I, Ouchida M, Ohno Y, Tsurumi T, Miki T, Wakamori M, Ishihara S, Yoshida T, Takizawa A, Kato M, Hirabayashi M, Sasa M, Mori Y, Serikawa T,. (2010) A missense mutation of the gene encoding voltage-dependent sodium channel (Nav1.1) confers susceptibility to febrile seizures in rats. J Neurosci 30: 5744-5753.
22. McLean M, (1999) Gabapentin in the management of convulsive disorders. Epilepsia 40 (suppl 6): S39-S50; discussion S73-S74. (Pubitemid 29481921)
23. Nieto-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR,. (2000) Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 9: 590-594. (Pubitemid 32094376)
24. Oakley JC, Kalume F, Yu FH, Scheuer T, Catterall WA,. (2009) Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. Proc Natl Acad Sci U S A 106: 3994-3999.
25. Offringa M, Moyer VA,. (2001) Evidence based paediatrics: evidence based management of seizures associated with fever. BMJ 323: 1111-1114. (Pubitemid 33063358)
26. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, Takeuchi T, Itohara S, Yanagawa Y, Obata K, Furuichi T, Hensch TK, Yamakawa K,. (2007) Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 27: 5903-5914. (Pubitemid 46849766)
27. Oguni H, Hayashi K, Oguni M, Mukahira A, Uehara T, Fukuyama Y, Umezu R, Izumi T, Hara M,. (1994) Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 35: 1140-1145. (Pubitemid 24379423)
28. Ogutu BR, Newton CR, Crawley J, Muchohi SN, Otieno GO, Edwards G, et al., (2002) Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. Br J Clin Pharmacol 53: 49-57. (Pubitemid 34117739)
29. Ohmori I, Ouchida M, Ohtsuka Y, Oka E, Shimizu K,. (2002) Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem Biophys Res Commun 295: 17-23. (Pubitemid 34743768)
30. Perez FA, Palmiter RD,. (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci U S A 102: 2174-2179. (Pubitemid 40262031)
31. Ryan M, Baumann RJ,. (1999) Use and monitoring of bromides in epilepsy treatment. Pediatr Neurol 21: 523-528. (Pubitemid 29366818)
32. Scheffer IE, Berkovic SF,. (1997) Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120: 479-490. (Pubitemid 27153640)
33. Schmidt D,. (2009) Drug treatment of epilepsy: options and limitations. Epilepsy Behav 15: 56-65.
34. Schuchmann S, Schmitz D, Rivera C, Vanhatalo S, Salmen B, Mackie K, Sipilä ST, Voipio J, Kaila K,. (2006) Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis. Nat Med 12: 817-823. (Pubitemid 44050072)
35. Sendrowski K, Sobaniec W, Sobaniec-Lotowska ME, Artemowicz B,. (2007) Topiramate as a neuroprotectant in the experimental model of febrile seizures. Adv Med Sci 52 (suppl 1): 161-165.
36. Ullal GR, Satishchandra P, Shankar SK,. (1996) Hyperthermic seizures: an animal model for hot-water epilepsy. Seizure 5: 221-228. (Pubitemid 26345846)
37. Verity CM, Butler NR, Golding J,. (1985) Febrile convulsions in a national cohort followed up from birth. I-Prevalence and recurrence in the first five years of life. Br Med J (Clin Res Ed) 290: 1307-1310. (Pubitemid 15082105)
38. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA,. (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9: 1142-1149. (Pubitemid 44306307)
39. Ziemann AE, Schnizler MK, Albert GW, Severson MA, Howard MA III, Welsh MJ, Wemmie JA,. (2008) Seizure termination by acidosis depends on ASIC1a. Nat Neurosci 11: 816-822. (Pubitemid 351896673)